Publications (original articles or review articles) published in 2023 from OUS - Dept. of Gastroenterology (Div Medicine)
24 publications found
A multi-centre polyp detection and segmentation dataset for generalisability assessment
Sci Data, 10 (1), 75
DOI 10.1038/s41597-023-01981-y, PubMed 36746950
Long-term survival after liver transplantation in patients with common variable immunodeficiency
Liver Transpl, 29 (8), 894-899
DOI 10.1097/LVT.0000000000000130, PubMed 36932715
Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation
J Hepatol, 79 (4), 955-966
DOI 10.1016/j.jhep.2023.05.038, PubMed 37328069
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Lancet Gastroenterol Hepatol, 8 (5), 458-492
DOI 10.1016/S2468-1253(23)00003-1, PubMed 36871566
Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: the METS-microbiome study
Nat Commun, 14 (1), 5160
DOI 10.1038/s41467-023-40874-x, PubMed 37620311
Intraoperative distensibility measurement in POEM for achalasia: impact on patient outcome and associations with other outcome variables at 1-year follow-up
Surg Endosc, 37 (12), 9283-9290
DOI 10.1007/s00464-023-10494-z, PubMed 37880446
Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)
J Crohns Colitis, 17 (4), 497-503
DOI 10.1093/ecco-jcc/jjac156, PubMed 36239614
Risk of Cancer in Patients With Crohn's Disease 30 Years After Diagnosis (the IBSEN Study)
Crohns Colitis 360, 5 (4), otad057
DOI 10.1093/crocol/otad057, PubMed 37886706
Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study)
Scand J Gastroenterol, 58 (11), 1264-1270
DOI 10.1080/00365521.2023.2223709, PubMed 37337889
The impact of proton pump inhibitors on the course of ulcerative colitis: a cohort study of over 10,000 newly diagnosed patients in Norway
Scand J Gastroenterol, 59 (1), 46-51
DOI 10.1080/00365521.2023.2255710, PubMed 37681998
A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
Hepatology, 77 (3), 715-728
DOI 10.1002/hep.32773, PubMed 36056902
Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study
J Crohns Colitis, 17 (11), 1781-1790
DOI 10.1093/ecco-jcc/jjad094, PubMed 37279652
The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease
Crohns Colitis 360, 5 (2), otad006
DOI 10.1093/crocol/otad006, PubMed 36937140
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
BMC Gastroenterol, 23 (1), 255
DOI 10.1186/s12876-023-02889-y, PubMed 37501083
Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type
Scand J Gastroenterol, 58 (8), 874-882
DOI 10.1080/00365521.2023.2177884, PubMed 36788656
Patient-reported nausea after implementation of an enhanced recovery after surgery protocol for gynae-oncology patients
Int J Gynecol Cancer, 33 (8), 1287-1294
DOI 10.1136/ijgc-2023-004356, PubMed 37451689
Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study
Int J Drug Policy, 116, 104044
DOI 10.1016/j.drugpo.2023.104044, PubMed 37149914
ERCP for the initial management of malignant biliary obstruction - real world data on 596 procedures
Scand J Gastroenterol, 59 (3), 369-377
DOI 10.1080/00365521.2023.2282375, PubMed 37994406
Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III)
Qual Life Res, 32 (10), 2951-2964
DOI 10.1007/s11136-023-03435-9, PubMed 37219727
Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs
Int J Drug Policy, 123, 104279
DOI 10.1016/j.drugpo.2023.104279, PubMed 38061225
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Lancet Gastroenterol Hepatol, 8 (10), 879-907
DOI 10.1016/S2468-1253(23)00197-8, PubMed 37517414
Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial
Lancet Diabetes Endocrinol, 11 (8), 555-566
DOI 10.1016/S2213-8587(23)00127-4, PubMed 37414071
Ad hoc digital communication and assessment during clinical placements in nursing education; a qualitative research study of students', clinical instructors', and teachers' experiences
PLoS One, 18 (7), e0287438
DOI 10.1371/journal.pone.0287438, PubMed 37478099
Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring
Scand J Gastroenterol, 58 (8), 863-873
DOI 10.1080/00365521.2023.2176252, PubMed 36799155